MKI67 and neoplasm: Subsequent immunohistochemical analysis of the resected tumor tissues using Ki67 and 4-HNE (a biomarker for lipid peroxidation) revealed a significant downregulation of Ki67 expression in tumors from the NR2 treatment group, indicating an inhibition of proliferation (Fig. S7A).